Encompass Health Corporation (EHC) 当前追踪市盈率 (P/E) 为 18.9, 前瞻市盈率为 18.0. 追踪盈利收益率为 5.29%, 前瞻盈利收益率 5.55%. PEG 0.77 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $64.47.
本页证实的标准:
SharesGrow 综合评分： 70/100 其中 3/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 11.8 | 0.32 | 3.97 | 0.80 | 2.87% |
| 2017 | 13.6 | -9.40 | 3.12 | 0.94 | 2.49% |
| 2018 | 16.4 | 1.73 | 3.61 | 1.12 | 2.10% |
| 2019 | 15.0 | 0.68 | 3.99 | 1.17 | 2.01% |
| 2020 | 22.8 | -1.07 | 4.08 | 1.82 | 1.73% |
| 2021 | 12.5 | 0.28 | 2.69 | 1.28 | 2.18% |
| 2022 | 21.9 | -0.64 | 4.53 | 1.36 | 1.67% |
| 2023 | 18.9 | 0.63 | 4.03 | 1.38 | 0.91% |
| 2024 | 20.2 | 0.72 | 4.46 | 1.72 | 0.68% |
| 2025 | 18.8 | 0.78 | 4.37 | 1.80 | 0.67% |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $2.59 | $3.65B | $247.6M | 6.8% |
| 2017 | $2.69 | $3.92B | $256.3M | 6.5% |
| 2018 | $2.93 | $4.28B | $292.3M | 6.8% |
| 2019 | $3.61 | $4.61B | $358.7M | 7.8% |
| 2020 | $2.85 | $4.64B | $284.2M | 6.1% |
| 2021 | $4.11 | $5.12B | $412.2M | 8% |
| 2022 | $2.70 | $4.35B | $271M | 6.2% |
| 2023 | $3.47 | $4.8B | $352M | 7.3% |
| 2024 | $4.46 | $5.37B | $455.7M | 8.5% |
| 2025 | $5.55 | $5.94B | $566.2M | 9.5% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $5.92 | $5.52 – $6.05 | $6.42B | $6.4B – $6.43B | 8 |
| 2027 | $6.47 | $6.05 – $6.65 | $6.94B | $6.89B – $7B | 8 |
| 2028 | $7.04 | $6.95 – $7.12 | $7.45B | $7.45B – $7.45B | 2 |
| 2029 | $7.69 | $7.65 – $7.76 | $7.94B | $7.9B – $7.99B | 1 |
